PMID- 27780861 OWN - NLM STAT- MEDLINE DCOM- 20170526 LR - 20220321 IS - 1083-351X (Electronic) IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 291 IP - 49 DP - 2016 Dec 2 TI - p70S6K1 (S6K1)-mediated Phosphorylation Regulates Phosphatidylinositol 4-Phosphate 5-Kinase Type I gamma Degradation and Cell Invasion. PG - 25729-25741 AB - Phosphatidylinositol 4-phosphate 5-kinase type I gamma (PIPKIgamma90) ubiquitination and subsequent degradation regulate focal adhesion assembly, cell migration, and invasion. However, it is unknown how upstream signals control PIPKIgamma90 ubiquitination or degradation. Here we show that p70S6K1 (S6K1), a downstream target of mechanistic target of rapamycin (mTOR), phosphorylates PIPKIgamma90 at Thr-553 and Ser-555 and that S6K1-mediated PIPKIgamma90 phosphorylation is essential for cell migration and invasion. Moreover, PIPKIgamma90 phosphorylation is required for the development of focal adhesions and invadopodia, key machineries for cell migration and invasion. Surprisingly, substitution of Thr-553 and Ser-555 with Ala promoted PIPKIgamma90 ubiquitination but enhanced the stability of PIPKIgamma90, and depletion of S6K1 also enhanced the stability of PIPKIgamma90, indicating that PIPKIgamma90 ubiquitination alone is insufficient for its degradation. These data suggest that S6K1-mediated PIPKIgamma90 phosphorylation regulates cell migration and invasion by controlling PIPKIgamma90 degradation. CI - (c) 2016 by The American Society for Biochemistry and Molecular Biology, Inc. FAU - Jafari, Naser AU - Jafari N AD - From the Markey Cancer Center and. AD - the Veterans Affairs Medical Center, Lexington, Kentucky 40502. FAU - Zheng, Qiaodan AU - Zheng Q AD - From the Markey Cancer Center and. FAU - Li, Liqing AU - Li L AD - From the Markey Cancer Center and. FAU - Li, Wei AU - Li W AD - From the Markey Cancer Center and. FAU - Qi, Lei AU - Qi L AD - From the Markey Cancer Center and. FAU - Xiao, Jianyong AU - Xiao J AD - From the Markey Cancer Center and. FAU - Gao, Tianyan AU - Gao T AD - From the Markey Cancer Center and. FAU - Huang, Cai AU - Huang C AUID- ORCID: 0000-0003-4258-3841 AD - From the Markey Cancer Center and cai-huang@uky.edu. AD - the Veterans Affairs Medical Center, Lexington, Kentucky 40502. AD - the Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, Kentucky 40506 and. LA - eng GR - P30 CA177558/CA/NCI NIH HHS/United States GR - R01 CA133429/CA/NCI NIH HHS/United States PT - Journal Article DEP - 20161025 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - EC 2.7.1.- (Phosphotransferases (Alcohol Group Acceptor)) RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.1.68 (1-phosphatidylinositol-4-phosphate 5-kinase) RN - EC 2.7.11.1 (Ribosomal Protein S6 Kinases, 70-kDa) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 2.7.11.1 (ribosomal protein S6 kinase, 70kD, polypeptide 1) SB - IM MH - Animals MH - CHO Cells MH - Cell Movement/*physiology MH - Cricetinae MH - Cricetulus MH - Focal Adhesions/genetics/*metabolism MH - Humans MH - Phosphorylation/physiology MH - Phosphotransferases (Alcohol Group Acceptor)/genetics/*metabolism MH - *Proteolysis MH - Ribosomal Protein S6 Kinases, 70-kDa/genetics/*metabolism MH - TOR Serine-Threonine Kinases/genetics/metabolism MH - Ubiquitination/*physiology PMC - PMC5207268 OTO - NOTNLM OT - PIP5K1C OT - S6 kinase OT - cell invasion OT - cell migration OT - phosphatidylinositol kinase OT - protein degradation EDAT- 2016/10/27 06:00 MHDA- 2017/05/27 06:00 PMCR- 2017/12/02 CRDT- 2016/10/27 06:00 PHST- 2016/06/08 00:00 [received] PHST- 2016/10/22 00:00 [revised] PHST- 2016/10/27 06:00 [pubmed] PHST- 2017/05/27 06:00 [medline] PHST- 2016/10/27 06:00 [entrez] PHST- 2017/12/02 00:00 [pmc-release] AID - S0021-9258(20)34559-2 [pii] AID - M116.742742 [pii] AID - 10.1074/jbc.M116.742742 [doi] PST - ppublish SO - J Biol Chem. 2016 Dec 2;291(49):25729-25741. doi: 10.1074/jbc.M116.742742. Epub 2016 Oct 25.